---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-001941"
form_type: "8-K/A"
ticker: "PETV"
cik: "0001512922"
company_name: "PetVivo Holdings, Inc."
filed_at: "2023-01-19T23:59:59+00:00"
generated_at: "2026-06-20T13:06:25.666923+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PetVivo raises $1.42M gross via registered direct offering of 610,011 shares at $2.32/share

## Summary
- 610,011 shares sold at $2.32/share; gross proceeds $1,415,225.52.
- Net proceeds ~$1.39M after $25k expenses; closings on Jan 9 and Jan 13, 2023.
- Proceeds for commercialization of Spryng™ with OsteoCushion™ Tech, clinical trials, working capital.
- Offering directly to accredited investors; no placement agent.

## SEC filing metadata
- accession: 0001493152-23-001941
- form_type: 8-K/A
- ticker: PETV
- cik: 0001512922
- company_name: PetVivo Holdings, Inc.
- filed_at: 2023-01-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512922/000149315223001941/0001493152-23-001941-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512922/000149315223001941/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-001941
- JSON: https://secwatch.observer/filing/0001493152-23-001941.json
- Plain text: https://secwatch.observer/filing/0001493152-23-001941.txt

## Key facts
- Material Agreements
  PetVivo Holdings, Inc. amended Amended Purchase Agreement with certain accredited investors valued at $1,415,225.52 (effective 2023-01-05).
  - Action: amendment
  - Agreement: equity purchase
  - Counterparty: certain accredited investors
  - Value: $1,415,225.52
  - Effective: 2023-01-05
  source text: On January 5, 2023, PetVivo Holdings, Inc. (the “Company”) entered into an amended and restated securities purchase agreement with certain accredited investors (the “Amended Purchase Agreement”), pursuant to which the Company agreed to issue and sell an aggregate of 610,011 Registered Shares in the Registered Offering at a purchase price of $2.32 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1512922/000149315223001941/0001493152-23-001941-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.